Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Vanderborght

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cells|November 4, 2020
The Angiopoietin/Tie2 Pathway in Hepatocellular CarcinomaBart Vanderborght, Sander Lefere, Hans Van Vlierberghe, et al.
Cells|November 27, 2021
The Gut-Liver Axis in Chronic Liver Disease: A Macrophage PerspectiveKevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 24, 2021
NOX1 inhibition attenuates the development of a pro-tumorigenic environment in experimental hepatocellular carcinomaAstrid Vandierendonck, Helena Degroote, Bart Vanderborght, et al.
Oncotarget|January 5, 2021
Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse modelBart Vanderborght, Kevin De Muynck, Sander Lefere, et al.
Arquivos De Gastroenterologia|July 20, 2007
Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in BrazilFernanda Branco, Angelo Alves de Mattos, Gabriela Perdomo Coral, et al.
Oncology Reports|April 17, 2002
Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomasMaria Chiara Chindamo, Nelson Spector, Jorge A Segadas, et al.
EXCLI Journal|November 16, 2022
Expression of connexins and pannexins in diseased human liverKaat Leroy, Vânia Vilas-Boas, Eva Gijbels, et al.
Oncotarget|April 2, 2021
Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma modelsHelena Degroote, Sander Lefere, Astrid Vandierendonck, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Modeling Alzheimer's Disease Using Human Brain OrganoidsKarina Karmirian, Mariana Holubiec, Livia Goto-Silva, et al.
Genes & Diseases|April 4, 2023
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver diseaseEva Gijbels, Kevin De Muynck, Bart Vanderborght, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cells|November 4, 2020
The Angiopoietin/Tie2 Pathway in Hepatocellular CarcinomaBart Vanderborght, Sander Lefere, Hans Van Vlierberghe, et al.
Cells|November 27, 2021
The Gut-Liver Axis in Chronic Liver Disease: A Macrophage PerspectiveKevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 24, 2021
NOX1 inhibition attenuates the development of a pro-tumorigenic environment in experimental hepatocellular carcinomaAstrid Vandierendonck, Helena Degroote, Bart Vanderborght, et al.
Oncotarget|January 5, 2021
Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse modelBart Vanderborght, Kevin De Muynck, Sander Lefere, et al.
Arquivos De Gastroenterologia|July 20, 2007
Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in BrazilFernanda Branco, Angelo Alves de Mattos, Gabriela Perdomo Coral, et al.
Oncology Reports|April 17, 2002
Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomasMaria Chiara Chindamo, Nelson Spector, Jorge A Segadas, et al.
EXCLI Journal|November 16, 2022
Expression of connexins and pannexins in diseased human liverKaat Leroy, Vânia Vilas-Boas, Eva Gijbels, et al.
Oncotarget|April 2, 2021
Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma modelsHelena Degroote, Sander Lefere, Astrid Vandierendonck, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Modeling Alzheimer's Disease Using Human Brain OrganoidsKarina Karmirian, Mariana Holubiec, Livia Goto-Silva, et al.
Genes & Diseases|April 4, 2023
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver diseaseEva Gijbels, Kevin De Muynck, Bart Vanderborght, et al.
Pageof 3